Stock listing
NASDAQ:XNPT XenoPort Inc Stock
Follow XenoPort Inc into a list and get an email when it puts out news.
Last close · NASDAQ:XNPT
$7.07 USD
Close on Jul 5, 2016 · No longer trades
- Lowest – highest close
- $3.28 – $65.86 USDSince Jun 2, 2005 · lowest May 9, 2014 · highest Jan 18, 2008
Delisted NASDAQ:XNPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:XNPT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
XenoPort Inc on 6ix
- Decks
- 7 decks · latest Sep 15, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (September 2015) | Technical | 21 slides | Sep 15, 2015 |
| Investor Presentation (October 2014) | Investor deck | 45 slides | Oct 16, 2014 |
| Proxy Contest (June 2014) | Proxy contest | 50 slides | Jun 6, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 51 slides | May 29, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 49 slides | May 21, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 52 slides | May 21, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 25 slides | May 13, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John G. Freund Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past) | Director · May 2, 2006 – Jul 5, 2016 · Past |
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | Director · May 7, 2009 – Jul 5, 2016 · Past |
| Dennis M Fenton Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); AnaptysBio, Inc. (Director · Since at least Mar 5, 2018); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Pfenex Inc (Director · May 6, 2016 – May 5, 2017 · Past) | Director · May 17, 2016 – Jul 5, 2016 · Past |
| William Rieflin Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); RAPT Therapeutics Inc (Director · Oct 30, 2019 – May 22, 2024 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past) | Director · May 17, 2016 – Jul 5, 2016 · Past |
| Kim Richard | See Remarks · Jan 15, 2014 – Jul 5, 2016 · Past |
Log in to ask 6ix AI your own questions about XenoPort Inc.